LIVE MARKET TRACKER :   BSE SENSEX   30958.25      |    NSE NIFTY 9511.40    
GLOBAL MARKETS :  NASDAQ 6280.6597   +0.2460%    |    FSI London 7471.88   +0.64%    |    NIKKEI Japan 20153.35   +0.10%
  USD GBP EUR CAD AUD INR
USD - 0.7854 0.8924 1.3241 1.3171 64.4800
GBP 1.2733 - 1.1361 1.6859 1.6767 82.1154
EUR 1.1209 0.8809 - 1.4841 1.4761 72.2295
CAD 0.7553 0.5936 0.6742 - 0.9949 48.7010
AUD 0.7595 0.5965 0.6776 1.0055 - 48.9400
INR 0.0155 0.0122 0.0138 0.0206 0.0205 -
Indian-Commodity  :  Equity & Shares  :  Ipca Laboratories surges on reporting over two fold jump in Q1 net profit

Ipca Laboratories surges on reporting over two fold jump in Q1 net profit (12-Aug-2016)

Ipca Laboratories is currently trading at Rs. 529.50, up by 6.45 points or 1.23% from its previous closing of Rs. 523.05 on the BSE.

The scrip opened at Rs. 529.00 and has touched a high and low of Rs. 532.45 and Rs. 525.10 respectively. So far 52008 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 888.00 on 19-Aug-2015 and a 52 week low of Rs. 402.00 on 06-Jun-2016.

Last one week high and low of the scrip stood at Rs. 537.40 and Rs. 493.75 respectively. The current market cap of the company is Rs. 6682.24 crore.

The promoters holding in the company stood at 45.90%, while institutions and non-institutions held 37.89% and 16.21% respectively.

Ipca Laboratories has reported over two fold jump in its net profit at Rs 47.57 crore for the quarter ended June 30, 2016 as compared to Rs 20.92 crore for the same quarter in the previous year. The company's total income increased by 11.19% to Rs 847.03 crore for the quarter under review from Rs 761.79 crore for the corresponding quarter of the previous year

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company's income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.


Top News Today
Capital First to raise funds on private placement basis
(27-Jun-2017)

Capital First to raise funds on private placement basisCapital First has received an approval for issue of rated, listed, secured, redeemable, non-convertible debentures (NCDs) of Rs 25 crore plus green shoe option of Rs 25 crore on private placement basis.......click on news to read complete article.

NOCIL gets nod to sell 4.71 lakh shares of NFIL
(27-Jun-2017)

NOCIL gets nod to sell 4.71 lakh shares of NFILNOCIL has received an approval to sell 4,71,015 shares of Navin Fluorine International (NFIL). The board of directors at its meeting held on June 23, 2017 has approved for the same.NOCIL is an India-based......click on news to read complete article.

Pennar Engineered gets nod to set up JV in USA
(27-Jun-2017)

Pennar Engineered gets nod to set up JV in USAPennar Engineered Building Systems has received an approval to set up a joint venture (JV) in the United States of America to supply their goods and services. The Finance and Operational Committee of the......click on news to read complete article.

International Stock News
US markets closed mostly higher on Monday
(27-Jun-2017)

US markets closed mostly higher on MondayThe US markets closed mostly higher on Monday, but the Nasdaq Composite faltered, putting pressure on the broader market. The Atlanta Federal Reserve's GDP Now forecast model showed that the US economy......click on news to read complete article.

US markets end mostly in green of Friday
(24-Jun-2017)

US markets end mostly in green of FridayThe US markets ended the choppy day of trade mostly in green on Friday, as traders took some support with report from the Commerce Department showing a rebound in new home sales in the month of May. The......click on news to read complete article.

US markets closed mostly lower on Thursday
(23-Jun-2017)

US markets closed mostly lower on ThursdayThe US markets closed mostly lower on Thursday, as weak financials and consumer staples shares eclipsed a rally in the health-care and biotechnology sectors. The Federal Reserve said that the 34 largest......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.